Ibandronate Sodium Tablet
Product Images NDC 55111-575

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Ibandronate Sodium (NDC 55111-575). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Blistercard (Blistercard)

FDA Label Image

Carton

This text appears to be a description of a medication called Ibandronate Sodium Tablet, 150 mg* used in the treatment of Osteoporosis. It is taken orally once a month as prescribed by a doctor, in the form of three 150-mg tablets. The tablets should be kept in controlled room temperature and dispensed with an important medication guide. The rest of the text contains information on the chemical composition and warnings regarding usage.*

FDA Label Image

Innercarton (Innercarton)

This text appears to be a medication guide for a once-monthly osteoporosis therapy called Ibandronate Sodium Tablet. The guide provides instructions for opening the package and taking the medication, but some parts of the text are not readable due to errors. The manufacturer is mentioned as Or.Reddys Laboratories Limited, and the dosage information is advised to be seen on the package insert. The text also provides storage instructions.*

FDA Label Image

Outercarton (Outercarton)

FDA Label Image

Pouch (Pouch)

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.